Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 12345 Next »
Viewing Page 1 of 5 | Showing Results 1 - 5 of 23

Multicenter 1-year Observational Study of Patients who are Initiating Brivaracetam

The purpose of this study is to examine how often brivaracetam treatment continues at 12 months, and the reasons why the drug was stopped (if...

Evan Fertig, M.D.
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center

BIP - A Randomized, Double-blind, Double-dummy, Parallel-group Study Comparing the Efficacy and Safety of Ofatumumab Versus Teriflunomide in Patients With Relapsing Multiple Sclerosis

The purpose of this study is to compare the efficacy and safety of ofatumumab administered subcutaneously (sc) every 4 weeks versus teriflunomide...

Stanley Cohan, M.D., Ph.D.
  • Providence St. Vincent Medical Center

Measurement of Relaxin in the Serum and Cerebrospinal Fluid of Subjects With and Without the Relapsing Form of Multiple Sclerosis

This study will evaluate relaxin (RLX) levels in patients with multiple sclerosis. Key Eligibilities: -Females 18 to 45 years of age. -Patients...

Stanley Cohan, M.D., Ph.D.
  • Providence St. Vincent Medical Center

Measuring the Impact of Tecfidera on the Gut Microbiota: Does a Change in the Gut Flora Correlate With Gastrointestinal Disturbances Following Therapy Initiation?

The primary objectives of this study are to determine whether a measureable change in bacterial species representation follows the institution of...

Kyle E Smoot, M.D.
  • Providence St. Vincent Medical Center

Effect of MD1003 in Progressive Multiple Sclerosis: a Randomized Double Blind Placebo Controlled Study

The purpose of this study is to demonstrate the superiority of MD1003 over placebo in the disability of patients suffering from progressive...

Kyle E Smoot, M.D.
  • Providence St. Vincent Medical Center
« Previous 12345 Next »
Viewing Page 1 of 5 | Showing Results 1 - 5 of 23